Q3 2025 product sales of $22.5 million, representing 129% growth over Q3 2024 and 19th straight quarter of sequential product ...
TipRanks on MSN
Eton Pharmaceuticals Reports Strong Q3 2025 Growth
Eton Pharmaceuticals ( ($ETON) ) has released its Q3 earnings. Here is a breakdown of the information Eton Pharmaceuticals presented to its ...
DEER PARK, Ill., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc ("Eton” or the "Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing ...
Eton Pharmaceuticals Added to Russell 3000® and Russell 2000® Indexes as Part of 2025 Reconstitution
Eton Pharmaceuticals has been added to the Russell 3000® and Russell 2000® Indexes, enhancing its visibility among investors and demonstrating its growth and shareholder value over the past year. The ...
Discover Eton Pharmaceuticals' Q3 2025 record results, rare disease growth, margin outlook, and expansion plans.
DEER PARK, Ill., May 01, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing ...
Eton Pharmaceuticals (($ETON)) has held its Q3 earnings call. Read on for the main highlights of the call. Eton Pharmaceuticals recently held its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback